Abstract
Endothelin-1 (ET-1), a 21 amino acid peptide originally purified from conditioned medium of cultures of porcine aortic endothelial cells, is recognized also as a product of many other cells such as epithelial cells, glial cells, and neurons. It is now recognized that at least ET-1 plays an important role in bone metabolism. It has been shown that ET-1 inhibits osteoclast bone resorption by a direct effect on cell motility and it can also activate phospholipase C in the osteoblast. Furthermore, several studies have shown that ET-1 stimulates the formation of inositol phosphates, the synthesis of DNA, the mobilization of calcium from extra- and intracellular pools, the activation of phospholipase D, and the stimulation of tyrosine phosphorylation in osteoblast-like (MC3T3-E1 and UMR-106) cells. The aim of the present study was to detect and characterize the presence of endothelin in transformed human osteoblast cell culture medium (HTb96) by radio-immunoassay and chromatography methods. Immunoreactive endothelin (IR-ET) was undetectable in the medium incubated at 0.5 and 1 h and was 3.2±0.2 fmol/105 cells (mean ± SEM, n=6) at 2 h, 9.5±0.5 fmol/105 cells at 6 h, 19.8 ± 2.1 fmol/105 cells at 24 h, and 23.7 ± 2.0 fmol/105 cells at 48 h, respectively. Sephadex G-25 superfine chromatography and fast protein liquid chromatography studies showed that >90% of IR-ET in the culture medium coeluted with synthetic ET-1. These results show that ET-1 could be formed by transformed human osteoblasts. Further studies should be conducted to elucidate the physiological role of endothelins as possible autocrine, paracrine, or endocrine factors in calcium and bone metabolism.
Similar content being viewed by others
References
Rodan, G. A., Bourret, L. A., Harvey, A., and Mervi, T. (1975). Science 189, 467–469.
Silve, C. M., Hradek, G. T., Jones, A. L., and Arnaud, C.D. (1982). J. Cell. Biol. 94, 379–386.
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., et al. (1988). Nature 332, 411–415.
Macrae, A. D. and Bloom, S. R. (1992). Trends Endocrinol. Metab. 3, 153–157.
Stern, P. H., Tatrai, A., Semler, D. E., Lee, S. K., Lakatos, P., Strieleman, P. J., et al. (1995). J. Nutr. 125, 20,28S-20,32S.
Sasaki, T. and Hong, M.H. (1993). Anat. Rec. 237, 332–337.
Semler, D., Ohlstein, E. H., Nambi, P., Slatter, C., and Stern, P. H. (1995). J. Pharmacol. Exp. Therap. 272, 1052–1058.
Nambi, P., Wu, H. L., Lipshutz, D., and Prabhakar, U. (1995). Mol. Pharmacol. 47, 266–271.
Hierl, T., Borcsok, I., Sommer, U., Ziegler, R., and Kasperk, C. (1998). Exp. Clin. Endocrinol. Diabetes 106, 324–333.
Hiruma, Y., Inoue, A., Shiohama, A., Otsuka, E., Hirose, S., Yamaguchi, A., et al. (1998). Am. J. Physiol. 275, R1099-R1105.
Hiruma, Y., Inoue, A., Shiohama, A., Otsuka, E., Hirose, S., Yamaguchi, A., et al. (1998). J. Cardiovasc. Pharmacol. 31(Suppl. 1), S521-S523.
Gilbey, S. G., Ghatei, M. A., Brecherton-Watt, D., Zaidi, M., Jones, P. M., Perera, T., et al. (1991). Clin. Sci. 81, 803–808.
Colston, K. W., King, R. J., Hayward, J., Fraser, D. I., Horton, M. A., and Stevenson, J. C. (1989). J. Bone Miner. Res. 4, 625–631.
Takahashi, K., Brooks, R. A., Kanse, S. M., Ghatei, M. A., Kohner, E. M., and Bloom, S. R. (1989). Diabetes 38, 1200–1202.
Lam, H. C., Takahashi, K., Ghatei, M. A., and Bloom, S. R. (1990). FEBS Lett. 261, 184–186.
Takahashi, K., Jones, P. M., Kanse, S. M., Lam, H. C., Spokes, R. A., Ghatei, M. A. et al. (1990). Gastroenterology 99, 1660–1667.
Kasperk, C. H., Börcsök, I., Schairer, H. U., Schneider, U., Nawroth, P. P., Niethard, F. U., et al. (1997). Calcif. Tissue Int. 60, 368–374.
Schvartz, I., Ittoop, O., Davidai, G., and Hazum, E. (1992). Peptides 13, 159–163.
Shioide, M., and Noda, M. (1993). J. Cell Biochem. 53, 176–180.
Takuwa, Y., Ohue, Y., Takuwa, N., and Yamashita, K. (1989). Am. J. Physiol. 257, E797-E803.
Takuwa, Y., Masaki, T., and Yamashita, K. (1990). Biochem. Biophys. Res. Commun. 170, 998–1005.
Suzuki, A., Oiso, Y., and Kozawa, O. (1994). Mol. Cell Endocrinol. 105, 193–196.
Tatrai, A. and Stern, P. H. (1993). J. Bone Miner. Res. 8, 943–952.
Lee, S. K. and Stern, P. H. (1995). J. Bone Miner.Res. 10, 1343–1351.
Tatrai, A., Laktos, P., Thompson, S., and Stern, P. H. (1992). J. Bone Miner. Res. 7, 1201–1209.
Gruber, H. E., Ivey, J. L., Thompson, E. R., Chesnut, C. H., and Baylink, D. J. (1986). Miner. Electrolyte Metab. 12, 246–254.
Alam, A. S.M. T., Gallagher, A., Shankar, V. S., Ghatei, M. A., Datta, H. K., Huang, C. L.-H., et al. (1992). Endocrinology 130, 3617–3624.
Tatrai, A., Foster, S., Lakatos, P., Shankar, G., and Stern, P. H. (1992). Endocrinology 139, 1268–1277.
Leis, H. J., Zach, D., Huber, E., and Windischhofer W. (1998). Endocrinology 139, 1268–1277.
Eguchi, S., Hirata, Y., Imai, T., Kanno, K., Akiba, T., Sakamoto, A., et al. (1992). Biochem. Biophys. Res. Commun. 184, 1448–1455.
Nomura, K., Yamashita, J. and Ogawa, M. (1994). J. Endocrinol. 143, 343–351.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lam, HC., Lee, JK. & Lai, KH. Detection and characterization of endothelin in transformed human osteoblast cell culture medium. Endocr 12, 77–80 (2000). https://doi.org/10.1385/ENDO:12:1:77
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:12:1:77